Giridhar, K.V.; Sosa, C.P.; Hillman, D.W.; Sanhueza, C.; Dalpiaz, C.L.; Costello, B.A.; Quevedo, F.J.; Pitot, H.C.; Dronca, R.S.; Ertz, D.;
et al. Whole Blood mRNA Expression-Based Prognosis of Metastatic Renal Cell Carcinoma. Int. J. Mol. Sci. 2017, 18, 2326.
https://doi.org/10.3390/ijms18112326
AMA Style
Giridhar KV, Sosa CP, Hillman DW, Sanhueza C, Dalpiaz CL, Costello BA, Quevedo FJ, Pitot HC, Dronca RS, Ertz D,
et al. Whole Blood mRNA Expression-Based Prognosis of Metastatic Renal Cell Carcinoma. International Journal of Molecular Sciences. 2017; 18(11):2326.
https://doi.org/10.3390/ijms18112326
Chicago/Turabian Style
Giridhar, Karthik V., Carlos P. Sosa, David W. Hillman, Cristobal Sanhueza, Candace L. Dalpiaz, Brian A. Costello, Fernando J. Quevedo, Henry C. Pitot, Roxana S. Dronca, Donna Ertz,
and et al. 2017. "Whole Blood mRNA Expression-Based Prognosis of Metastatic Renal Cell Carcinoma" International Journal of Molecular Sciences 18, no. 11: 2326.
https://doi.org/10.3390/ijms18112326
APA Style
Giridhar, K. V., Sosa, C. P., Hillman, D. W., Sanhueza, C., Dalpiaz, C. L., Costello, B. A., Quevedo, F. J., Pitot, H. C., Dronca, R. S., Ertz, D., Cheville, J. C., Donkena, K. V., & Kohli, M.
(2017). Whole Blood mRNA Expression-Based Prognosis of Metastatic Renal Cell Carcinoma. International Journal of Molecular Sciences, 18(11), 2326.
https://doi.org/10.3390/ijms18112326